Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Reenaers C, Louis E, Belaiche J, Seidel L, Keshav S, Travis S. Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply. Aliment Pharmacol Ther 2013;37:752-3. [PMID: 23458531 DOI: 10.1111/apt.12245] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/23/2013] [Accepted: 01/23/2013] [Indexed: 12/08/2022]

For:	Reenaers C, Louis E, Belaiche J, Seidel L, Keshav S, Travis S. Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply. Aliment Pharmacol Ther 2013;37:752-3. [PMID: 23458531 DOI: 10.1111/apt.12245] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/23/2013] [Accepted: 01/23/2013] [Indexed: 12/08/2022]

Number	Cited by Other Article(s)
1	Reenaers C, Louis E, Belaiche J, Seidel L, Keshav S, Travis S. Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply. Aliment Pharmacol Ther 2013;37:752-3. [PMID: 23458531 DOI: 10.1111/apt.12245] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/23/2013] [Accepted: 01/23/2013] [Indexed: 12/08/2022] Abstract Collapse Key Words Collapse MESH Headings Antibodies, Monoclonal, Humanized/therapeutic use Crohn Disease/drug therapy Female Humans Immunosuppressive Agents/therapeutic use Male Tumor Necrosis Factor-alpha/antagonists & inhibitors Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Reenaers C, Louis E, Belaiche J, Seidel L, Keshav S, Travis S. Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply. Aliment Pharmacol Ther 2013;37:752-3. [PMID: 23458531 DOI: 10.1111/apt.12245] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/23/2013] [Accepted: 01/23/2013] [Indexed: 12/08/2022]